Americas Anticholinergic Drugs market

United states accounted for the largest market share in 2017 in the americas anticholinergic drugs market, and is expected to reach usd 1924.41 million in 2024 from usd 1357.82 million in 2017.this market is projected to grow at a cagr of 5.11% during the forecast period from 2018 - 2024. oral segment accounted for the largest market share in 2017, this market is expected to reach usd 1727.96 million in 2024 from usd 1278.18 million in 2017. this market is projected to grow at a cagr of 4.40% during the forecast period from 2018 - 2024. however, parenteral segment is the fastest growing market, which is expected to grow at a cagr of 4.80% during the forecast period 2018 - 2024. hospital segment accounted for the largest market share in 2017, this market is expected to reach usd 1694.30 million in 2024 from usd 1210.19 million in 2017. this market is projected to grow at a cagr of 4.92% during the forecast period from 2018 - 2024. synthetic compounds segment accounted for the largest market share in 2017, this market is expected to reach usd 1854.69 million in 2024 from usd 1328.69 million in 2017. this market is projected to grow at a cagr of 4.88% during the forecast period from 2018 - 2024. however, synthetic compounds segment is the fastest growing market, which is expected to grow at a cagr of 4.88% during the forecast period 2018 - 2024. overactive bladder segment accounted for the largest market share in 2017, this market is expected to reach usd 1022.42 million in 2024 from usd 774.69 million in 2017. this market is projected to grow at a cagr of 4.04% during the forecast period from 2018 - 2024. however, parkinson's disease segment is the fastest growing market, which is expected to grow at a cagr of 4.91% during the forecast period 2018 - 2024.